FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:963-969 October 2, 1997 Number 14 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Many patients with cystic fibrosis are malnourished at the time of diagnosis. Whether newborn screening and early treatment may prevent the development of a nutritional deficiency is not known.

Methods We compared the nutritional status of patients with cystic fibrosis identified by neonatal screening or by standard diagnostic methods. A total of 650,341 newborn infants were screened by measuring immunoreactive trypsinogen on dried blood spots (from April 1985 through June 1991) or by combining the trypsinogen test with DNA analysis (from July 1991 through June 1994). Of 325,171 infants assigned to an early-diagnosis group, cystic fibrosis was diagnosed in 74 infants, including 5 with negative screening tests. Excluding infants with meconium ileus, we evaluated nutritional status for up to 10 years by anthropometric and biochemical methods in 56 of the infants who received an early diagnosis and in 40 of the infants in whom the diagnosis was made by standard methods (the control group). Pancreatic insufficiency was managed with nutritional interventions that included high-calorie diets, pancreatic-enzyme therapy, and fat-soluble vitamin supplements.

Results The diagnosis of cystic fibrosis was confirmed by a positive sweat test at a younger age in the early-diagnosis group than in the control group (mean age, 12 vs. 72 weeks). At the time of diagnosis, the early-diagnosis group had significantly higher height and weight percentiles and a higher head-circumference percentile (52nd, vs. 32nd in the control group; P = 0.003). The early-diagnosis group also had significantly higher anthropometric indexes during the follow-up period, especially the children with pancreatic insufficiency and those who were homozygous for the F508 mutation.

Conclusions Neonatal screening provides the opportunity to prevent malnutrition in infants with cystic fibrosis.

Source Information

From the Department of Pediatrics and Biostatistics, University of Wisconsin, Madison (P.M.F., M.R.K., A.L., G.S., R.E.K.), and the Department of Pediatrics, Medical College of Wisconsin, Milwaukee (W.T.B., M.S., E.H.M.).

Address reprint requests to Dr. Farrell at the University of Wisconsin Medical School, 1300 University Ave., Madison, WI 53706.

Full Text of this Article

This article has been cited by other articles:

• Smyth, A. R., Barbato, A., Beydon, N., Bisgaard, H., de Boeck, K., Brand, P., Bush, A., Fauroux, B., de Jongste, J., Korppi, M., O'Callaghan, C., Pijnenburg, M., Ratjen, F., Southern, K., Spencer, D., Thomson, A., Vyas, H., Warris, A., Merkus, P. J. (2010). Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J 35: 247-265 [Abstract] [Full Text]  
• Stafler, P., Wallis, C. (2009). Extra corporeal membrane oxygenation (ECMO) therapy in a 3-year-old child with cystic fibrosis: a tale of hope. JRSM 102: 54-58 [Full Text]  
• Lai, H. J., Shoff, S. M., Farrell, P. M., with the Wisconsin Cystic Fibrosis Neonatal Screen, (2009). Recovery of Birth Weight z Score Within 2 Years of Diagnosis Is Positively Associated With Pulmonary Status at 6 Years of Age in Children With Cystic Fibrosis. Pediatrics 123: 714-722 [Abstract] [Full Text]  
• Kloosterboer, M., Hoffman, G., Rock, M., Gershan, W., Laxova, A., Li, Z., Farrell, P. M. (2009). Clarification of Laboratory and Clinical Variables That Influence Cystic Fibrosis Newborn Screening With Initial Analysis of Immunoreactive Trypsinogen. Pediatrics 123: e338-e346 [Abstract] [Full Text]  
• Kremer, T. M., Zwerdling, R. G., Michelson, P. H., O'Sullivan, B. P. (2008). Intensive Care Management of the Patient With Cystic Fibrosis. J Intensive Care Med 23: 159-177 [Abstract]  
• Balfour-Lynn, I. M (2008). Newborn screening for cystic fibrosis: evidence for benefit. Arch. Dis. Child. 93: 7-10 [Full Text]  
• Bishop Hubbard, H. (2007). Policy Issues Related to Expanded Newborn Screening: A Review of Three Genetic/Metabolic Disorders. Policy Politics Nursing Practice 8: 201-209 [Abstract]  
• Mayer-Hamblett, N., Ramsey, B. W., Kronmal, R. A. (2007). Advancing Outcome Measures for the New Era of Drug Development in Cystic Fibrosis. Proc Am Thorac Soc 4: 370-377 [Abstract] [Full Text]  
• Bell, S. C, Robinson, P. J (2007). Exacerbations in cystic fibrosis: 2 {middle dot} Prevention. Thorax 62: 723-732 [Abstract] [Full Text]  
• Padman, R., McColley, S. A., Miller, D. P., Konstan, M. W., Morgan, W. J., Schechter, M. S., Ren, C. L., Wagener, J. S., for the Investigators and Coordinators of the Epid, (2007). Infant Care Patterns at Epidemiologic Study of Cystic Fibrosis Sites That Achieve Superior Childhood Lung Function. Pediatrics 119: e531-e537 [Abstract] [Full Text]  
• Sims, E. J., Clark, A., McCormick, J., Mehta, G., Connett, G., Mehta, A., on behalf of the United Kingdom Cystic Fibrosis Da, (2007). Cystic Fibrosis Diagnosed After 2 Months of Age Leads to Worse Outcomes and Requires More Therapy. Pediatrics 119: 19-28 [Abstract] [Full Text]  
• Sawyer, S. M., Cerritelli, B., Carter, L. S., Cooke, M., Glazner, J. A., Massie, J. (2006). Changing Their Minds With Time: A Comparison of Hypothetical and Actual Reproductive Behaviors in Parents of Children With Cystic Fibrosis. Pediatrics 118: e649-e656 [Abstract] [Full Text]  
• Shoff, S. M., Ahn, H.-Y., Davis, L., Lai, H., the Wisconsin CF Neonatal Screening Group, (2006). Temporal Associations Among Energy Intake, Plasma Linoleic Acid, and Growth Improvement in Response to Treatment Initiation After Diagnosis of Cystic Fibrosis. Pediatrics 117: 391-400 [Abstract] [Full Text]  
• Corech, R., Rao, A., Laxova, A., Moss, J., Rock, M. J., Li, Z., Kosorok, M. R., Splaingard, M. L., Farrell, P. M., Barbieri, J. T. (2005). Early Immune Response to the Components of the Type III System of Pseudomonas aeruginosa in Children with Cystic Fibrosis. J. Clin. Microbiol. 43: 3956-3962 [Abstract] [Full Text]  
• Smyth, R. L (2005). Diagnosis and management of cystic fibrosis. EDUCATION AND PRACTICE 90: ep1-ep6 [Full Text]  
• Li, Z., Kosorok, M. R., Farrell, P. M., Laxova, A., West, S. E. H., Green, C. G., Collins, J., Rock, M. J., Splaingard, M. L. (2005). Longitudinal Development of Mucoid Pseudomonas aeruginosa Infection and Lung Disease Progression in Children With Cystic Fibrosis. JAMA 293: 581-588 [Abstract] [Full Text]  
• Johnson, S. C., Marshall, D. J., Harms, G., Miller, C. M., Sherrill, C. B., Beaty, E. L., Lederer, S. A., Roesch, E. B., Madsen, G., Hoffman, G. L., Laessig, R. H., Kopish, G. J., Baker, M. W., Benner, S. A., Farrell, P. M., Prudent, J. R. (2004). Multiplexed Genetic Analysis Using an Expanded Genetic Alphabet. Clin. Chem. 50: 2019-2027 [Abstract] [Full Text]  
• Sawyer, S. M., Glazner, J. A. (2004). What Follows Newborn Screening? An Evaluation of a Residential Education Program for Parents of Infants With Newly Diagnosed Cystic Fibrosis. Pediatrics 114: 411-416 [Abstract] [Full Text]  
• Koscik, R. L., Farrell, P. M., Kosorok, M. R., Zaremba, K. M., Laxova, A., Lai, H.-C., Douglas, J. A., Rock, M. J., Splaingard, M. L. (2004). Cognitive Function of Children With Cystic Fibrosis: Deleterious Effect of Early Malnutrition. Pediatrics 113: 1549-1558 [Abstract] [Full Text]  
• Comeau, A. M., Parad, R. B., Dorkin, H. L., Dovey, M., Gerstle, R., Haver, K., Lapey, A., O'Sullivan, B. P., Waltz, D. A., Zwerdling, R. G., Eaton, R. B. (2004). Population-Based Newborn Screening for Genetic Disorders When Multiple Mutation DNA Testing Is Incorporated: A Cystic Fibrosis Newborn Screening Model Demonstrating Increased Sensitivity but More Carrier Detections. Pediatrics 113: 1573-1581 [Abstract] [Full Text]  
• Farrell, P. M., Li, Z., Kosorok, M. R., Laxova, A., Green, C. G., Collins, J., Lai, H.-C., Rock, M. J., Splaingard, M. L. (2003). Bronchopulmonary Disease in Children with Cystic Fibrosis after Early or Delayed Diagnosis. Am. J. Respir. Crit. Care Med. 168: 1100-1108 [Abstract] [Full Text]  
• (2003). American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. Am. J. Respir. Crit. Care Med. 168: 818-900 [Full Text]  
• Merelle, M. E., Huisman, J., Alderden-van der Vecht, A., Taat, F., Bezemer, D., Griffioen, R. W., Brinkhorst, G., Dankert-Roelse, J. E. (2003). Early Versus Late Diagnosis: Psychological Impact on Parents of Children With Cystic Fibrosis. Pediatrics 111: 346-350 [Abstract] [Full Text]  
• Assael, B. M., Castellani, C., Ocampo, M. B., Iansa, P., Callegaro, A., Valsecchi, M. G. (2002). Epidemiology and Survival Analysis of Cystic Fibrosis in an Area of Intense Neonatal Screening Over 30 Years. Am J Epidemiol 156: 397-401 [Abstract] [Full Text]  
• Lai, H.-C., Kosorok, M. R., Laxova, A., Makholm, L. M., Farrell, P. M. (2002). Delayed Diagnosis of US Females with Cystic Fibrosis. Am J Epidemiol 156: 165-173 [Abstract] [Full Text]  
• West, S. E. H., Zeng, L., Lee, B. L., Kosorok, M. R., Laxova, A., Rock, M. J., Splaingard, M. J., Farrell, P. M. (2002). Respiratory Infections With Pseudomonas aeruginosa in Children With Cystic Fibrosis: Early Detection by Serology and Assessment of Risk Factors. JAMA 287: 2958-2967 [Abstract] [Full Text]  
• Evans, A.K.C., Fitzgerald, D.A., McKay, K.O. (2001). The impact of meconium ileus on the clinical course of children with cystic fibrosis. Eur Respir J 18: 784-789 [Abstract] [Full Text]  
• Merelle, M.E., Schouten, J.P., Gerritsen, J., Dankert-Roelse, J.E. (2001). Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J 18: 306-315 [Abstract] [Full Text]  
• Grosse, S. D., Khoury, M. J., Hannon, W. H., Boyle;, C. A., Farrell, P. M. (2001). Early Diagnosis of Cystic Fibrosis. Pediatrics 107: 1492-1492 [Full Text]  
• (2001). Neonatal screening for cystic fibrosis. Arch. Dis. Child. 84: 449-449 [Full Text]  
• Ciske, D. J., Haavisto, A., Laxova, A., Rock, L. Z. M., Farrell, P. M. (2001). Genetic Counseling and Neonatal Screening for Cystic Fibrosis: An Assessment of the Communication Process. Pediatrics 107: 699-705 [Abstract] [Full Text]  
• Farrell, M. H., Certain, L. K., Farrell, P. M. (2001). Genetic Counseling and Risk Communication Services of Newborn Screening Programs. Arch Pediatr Adolesc Med 155: 120-126 [Abstract] [Full Text]  
• Wang, S. S., FitzSimmons, S. C., O'Leary, L. A., Rock, M. J., Gwinn, M. L., Khoury, M. J. (2001). Early Diagnosis of Cystic Fibrosis in the Newborn Period and Risk of Pseudomonas aeruginosa Acquisition in the First 10 Years of Life: A Registry-Based Longitudinal Study. Pediatrics 107: 274-279 [Abstract] [Full Text]  
• Farrell, P. M., Kosorok, M. R., Rock, M. J., Laxova, A., Zeng, L., Lai, H.-C., Hoffman, G., Laessig, R. H., Splaingard, M. L., the Wisconsin Cystic Fibrosis Neonatal Screening S, (2001). Early Diagnosis of Cystic Fibrosis Through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth. Pediatrics 107: 1-13 [Abstract] [Full Text]  
• Stettler, N., Kawchak, D. A, Boyle, L. L, Propert, K. J, Scanlin, T. F, Stallings, V. A, Zemel, B. S (2000). Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis. Am. J. Clin. Nutr. 72: 407-413 [Abstract] [Full Text]  
• Dudding, T., Wilcken, B., Burgess, B., Hambly, J., Turner, G. (2000). Reproductive decisions after neonatal screening identifies cystic fibrosis. Arch. Dis. Child. Fetal Neonatal Ed. 82: 124F-127 [Abstract] [Full Text]  
• Lai, H.-C., Kosorok, M. R., Laxova, A., Davis, L. A., FitzSimmon, S. C., Farrell, P. M. (2000). Nutritional Status of Patients With Cystic Fibrosis With Meconium Ileus: A Comparison With Patients Without Meconium Ileus and Diagnosed Early Through Neonatal Screening. Pediatrics 105: 53-61 [Abstract] [Full Text]  
• Sarles, J., Barthellemy, S., Férec, C., Iovanna, J., Roussey, M., Farriaux, J.-P., Toutain, A., Berthelot, J., Maurin, N., Codet, J.-P., Berthézène, P., Dagorn, J.-C. (1999). Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis. Arch. Dis. Child. Fetal Neonatal Ed. 80: 118F-122 [Abstract] [Full Text]  
• Waters, D. L, Wilcken, B., Irwig, L., Van Asperen, P., Mellis, C., Simpson, J. M, Brown, J., Gaskin, K. J (1999). Clinical outcomes of newborn screening for cystic fibrosis. Arch. Dis. Child. Fetal Neonatal Ed. 80: 1F-7 [Abstract] [Full Text]  
• Farrell, P. M (1998). Early diagnosis of cystic fibrosis can improve children's growth. BMJ 317: 1017-1017 [Full Text]  
• Dodge, J A, Lane, B., Harris, R., Harris, H., Pollitt, R. (1998). Neonatal screening for cystic fibrosis. BMJ 317: 411-411 [Full Text]  
• Wald, N. J, Morris, J. K (1998). Neonatal screening for cystic fibrosis. BMJ 316: 404-405 [Full Text]  
• Dankert-Roelse, J. E., te Meerman, G. J. (1997). Screening for Cystic Fibrosis -- Time to Change Our Position?. NEJM 337: 997-999 [Full Text]